Abstract:We found that the X chromosome status of human extended pluripotent stem cells (hEPSCs) were largely determined by the primed human embryonic stem cells (hESCs) from which they were derived, suggesting a lack of complete reprogramming of X chromosome during primed to extended/expanded pluripotency conversion. There were two distinct populations of hEPSCs derived from pre‐X chromosome inactivation (XCI) primed hESCs: HTG (with biallelic active X chromosomes and active RNA transcription) and LTG (with a partially monoallelic chromosome and prone to differentiation). hEPSCs derived from post‐XCI primed hESCs maintained monoallelic X chromosome status and lost XIST RNA coating. The chromosome status of hEPSCs affected their differentiation capability into embryonic or extraembryonic lineage cells. Different pluripotent cell types have been established by capturing pluripotency in different states. Human extended pluripotent stem cells (hEPSCs), recently established by two independent studies, have the capability of differentiating into both embryonic and extraembryonic lineages, as well as forming human blastoids, showing great potential for early human development modeling and regenerative medicine. Considering that X chromosome status in female human pluripotent stem cells is dynamic and heterogeneous, and often leads to functional consequences, we characterized it in hEPSCs. We derived hEPSCs from primed human embryonic stem cells (hESCs) with defined X chromosome status (pre‐ or post‐X chromosome inactivation) using two previously published methods. We showed that hEPSCs derived using both methods had highly similar transcription profiles and X chromosome status. However, the X chromosome status of hEPSCs is largely determined by the primed hESCs from which they were derived, suggesting a lack of complete reprogramming of X chromosome during primed to extended/expanded pluripotency conversion. Furthermore, we found that the X chromosome status of hEPSCs affected their ability to differentiate into embryonic or extraembryonic lineage cells. Taken together, our work characterized the X chromosome status of hEPSCs, providing important information for the future application of hEPSCs.

De-erosion of X chromosome dosage compensation by the editing of XIST regulatory regions restores the differentiation potential in hPSCs

Highly efficient XIST reactivation in female hPSC by transient dual inhibition of TP53 and DNA methylation during Cas9 mediated genome editing

Enhancement of Xrcc1-mediated Base Excision Repair Improves the Genetic Stability and Pluripotency of Ipscs

Erosion of X-Chromosome Inactivation in female hiPSCs is heterogeneous and persists during differentiation

Xist repression shows time-dependent effects on the reprogramming of female somatic cells to induced pluripotent stem cells.

Erosion of Human X Chromosome Inactivation Causes Major Remodeling of the Ipsc Proteome

X-inactivation in Female Human Embryonic Stem Cells is in a Nonrandom Pattern and Prone to Epigenetic Alterations

Dynamic Erasure of Random X-Chromosome Inactivation during iPSC Reprogramming

Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming

XIST dampens X chromosome activity in a SPEN-dependent manner during early human development

Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming

Characterisation of X chromosome status of human extended pluripotent stem cells

The Dynamic Changes of X Chromosome Inactivation During Early Culture of Human Embryonic Stem Cells

Xist deficiency and disorders of X-inactivation in rabbit embryonic stem cells can be rescued by transcription-factor-mediated conversion.

Integration of xeno-free single-cell cloning in CRISPR-mediated DNA editing of human iPSCs improves homogeneity and methodological efficiency of cellular disease modeling

Modeling X chromosome inactivation using t5iLA naive human pluripotent stem cells

X-chromosome inactivation in human iPSCs provides insight into X-regulated gene expression in autosomes

Tsix RNA and the germline factor, PRDM14, link X reactivation and stem cell reprogramming

Integrated analysis of Xist upregulation and X-chromosome inactivation with single-cell and single-allele resolution

Overcoming Autocrine FGF Signaling-Induced Heterogeneity in Naive Human ESCs Enables Modeling of Random X Chromosome Inactivation

Knockdown H19 Accelerated iPSCs Reprogramming through Epigenetic Modifications and Mesenchymal-to-Epithelial Transition